The European Union is committing €225 million to speed up the development of next-generation flu vaccines that will offer protection across a wider range of influenza variants and quickly adapted if a pandemic strain emerges. It marks the first time the Commission will be using pre-commercial procurement to advance products through clinical trials, ensuring they […]
HERA signs Joint Procurement contract for Pandemic Influenza Vaccine
Today, the European Commission, via its Health Emergency Preparedness and Response Authority, signed a framework contract for the joint procurement of Adjupanrix, a pandemic influenza vaccine, with the pharmaceutical company GSK. 12 Member States and other joint procurement countries are participating in the agreement, under which they can purchase up to 85,000,000 vaccine doses if necessary, in the […]